Ascletis Pha B
Ascletis Pharma Inc., commonly referred to as Ascletis, is a prominent biopharmaceutical company headquartered in China (CN). Founded in 2013, Ascletis has rapidly established itself in the biotechnology sector, focusing on the research, development, and commercialisation of innovative therapies for viral infections, liver diseases, and cancer. With a strong operational presence in major regions across Asia, Ascletis has achieved significant milestones, including the successful launch of its core products, which are distinguished by their advanced formulations and efficacy. The company is recognised for its commitment to addressing unmet medical needs, positioning itself as a leader in the competitive biopharmaceutical landscape. Ascletis continues to drive innovation, contributing to the global fight against serious health challenges.
DitchCarbon Score
How does Ascletis Pha B's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ascletis Pha B's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ascletis Pha B's reported carbon emissions
In 2021, Ascletis Pharma Inc., headquartered in China (CN), reported total carbon emissions of approximately 2,180,270 kg CO2e. This figure includes 14,630 kg CO2e from Scope 1 emissions and 2,165,640 kg CO2e from Scope 2 emissions, indicating a significant reliance on indirect emissions associated with energy consumption. Currently, Ascletis has not established any specific reduction targets or climate pledges, nor does it report on Scope 3 emissions. The absence of reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the organisation continues to navigate its environmental impact, it is essential for Ascletis to consider setting science-based targets and engaging in industry-standard climate commitments to enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 14,630 |
| Scope 2 | 2,165,640 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ascletis Pha B is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
